業績

日本内分泌学会　第5回若手臨床内分泌医奨励賞　Runners-Up賞　中田　健人先生

Oral Abstracts Presentation Award of the 17th International Congress on Antiphospholipid Antibodies and the APS Foundation of America　

藤枝 雄一郎  先生

Shindo T, Ito M, Sugiyama T, Okuyama T, Kono M, Atsumi T, Fujimura M.

Diagnostic Value of Vessel Wall Imaging to Determine the Timing of Extracranial-Intracranial Bypass for Moyamoya Syndrome Associated with Active Sjogren's Syndrome: A Case Report J Neurol Surg A Cent Eur Neurosurg, 2022

IF=1.268

Kato M*#, Kudo Y#, Hatase M, Tsuchida N, Takeyama S, Sugiyama T, Fujimura M, Yabe I, Tsujimoto H, Fukumori Y, Inoue N, Atsumi T.

Moyamoya disease associated with a deficiency of complement component 6.  (*: Correspondence, #: These authors contribute equally to this

work)

Journal of Stroke & Cerebrovascular Diseases. in press

IF：2.136

第66回日本リウマチ学会総会・学術集会　JCR 2022 ICW Excellent Abstract Award　崎山　広大先生

Yamauchi Y, Nakamura A, Yokota T, Takahashi K, Kawata S, Tsuchida K, Omori K, Nomoto H, Kameda H, Cho KY, Anzai T, Tanaka S, Terauchi Y, Miyoshi H, Atsumi T.

Luseogliflozin preserves the pancreatic beta-cell mass and function in db/db mice by improving mitochondrial function.

Sci Rep, in press.

IF: 4.380

Aika Miya, Akinobu Nakamura, Isao Yokota, Kyu Yong Cho, Hiraku Kameda, Hiroshi Nomoto, Takahiro Takase, Kazuno Omori, Mayuko Ono, So Nagai, Shinji Taneda, Hideaki Miyoshi, Tatsuya Atsumi The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community-based Integrated Care System 8-items (DASC-8): A cross-sectional study of elderly patients with diabetes Geriatrics and Gerontology International, in press

IF: 2.730

Nakamura J, Tsujino I, Ohira H, Nakaya T, Sugimoto A, Sato T, Watanabe T, Suzuki M, Kato M, Yokota I, Konno S.

Various factors contributing to death among patients with different types of pulmonary hypertension: A retrospective pilot study from a single tertiary center.

Respiratory Investigation. in press

Nakamura A.

Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Pancreatic Beta-Cell Mass and Function.

Int J Mol Sci, in press.

IF: 5.924

Hiroshi Nomoto, Sho Furusawa, Akinobu Nakamura, Jun Takeuchi, So Nagai, Hiroki Yokoyama, Ichiro Sakuma, Shinji Taneda, Yoshio Kurihara, Shin Aoki, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, and Hideaki Miyoshi Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes:

protocol for a multi-center, prospective, randomized, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study) BMJ Open, in press

IF: 2.692